Re: All-cause mortality in randomized trials of cancer screening

J Natl Cancer Inst. 2002 Jun 5;94(11):861-2; author reply 865-6. doi: 10.1093/jnci/94.11.861-a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Bias
  • Cause of Death*
  • Chemotherapy, Adjuvant / adverse effects
  • Female
  • Goserelin / adverse effects
  • Goserelin / therapeutic use
  • Humans
  • Male
  • Mass Screening / statistics & numerical data*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / mortality
  • Randomized Controlled Trials as Topic / statistics & numerical data*
  • Survival Rate

Substances

  • Antineoplastic Agents, Hormonal
  • Goserelin